The Eunice Kennedy Shriver National Institute of Child Health and Human Development, an institute of the National Institutes of Health, United States Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the patent applications listed in the Supplementary Information section of this notice to EnZeta Immunotherapies, Inc., a company located in Coral Gables, FL.
This is a notice published in the Federal Register by Health and Human Services Department, National Institutes of Health. Notices communicate information, guidance, or policy interpretations but may not create new binding obligations.
This document is classified as a notice. It may or may not create enforceable regulatory obligations depending on its specific content.
Notice.
Only written comments and/or applications for a license which are received by the National Cancer Institute's Technology Transfer Center, representing the Eunice Kennedy Shriver National Institute of Child Health and Human Development, on or before January 7, 2026 will be considered.
| Document Number | 2025-23691 |
| FR Citation | 90 FR 60111 |
| Type | Notice |
| Published | Dec 23, 2025 |
| Effective Date | - |
| RIN | - |
| Docket ID | - |
| Pages | 60111–60112 (2 pages) |
| Text Fetched | No |
| Part | Name | Agency |
|---|---|---|
| No linked CFR parts | ||
| Type | Proposed | Final | Method | Conf |
|---|---|---|---|---|
| No paired documents | ||||
The full text for this document hasn't been fetched yet. The system will automatically retrieve it during the next processing cycle.